[Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review]
- PMID: 16491229
- DOI: 10.1590/s0004-27492006000100005
[Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review]
Abstract
Purpose: To evaluate the characteristics of the essential blepharospasm and hemifacial spasm patients and the feasible treatment with botulinum toxin A.
Methods: Thirty-four essential blepharospasm or hemifacial spasm patients were evaluated according to gender, ocular complaint, time of disease, treatment outcome and complications.
Results: Age median was 63 years and the mean was 61 years, with no difference regarding sex; 66.66% of the patients had hemifacial spasm and 33.33%, essential blepharospasm. Many patients complained of dry eye associated with involuntary spasm. Botulinum toxin A showed a positive outcome in 91.30% of the treated patients and complications observed after treatment were eyelid ptosis (8.33%) and buccal angle deviation (8.33%).
Conclusion: Essential blepharospasm and hemifacial spasm occurred in the elderly, of both sexes. Treatment with botulinum toxin A was useful, with very low complication rates.
Similar articles
-
Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.Clin Exp Ophthalmol. 2014 Apr;42(3):254-61. doi: 10.1111/ceo.12165. Epub 2013 Aug 4. Clin Exp Ophthalmol. 2014. PMID: 23844601
-
The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.Kathmandu Univ Med J (KUMJ). 2010 Jul-Sep;8(31):305-10. doi: 10.3126/kumj.v8i3.6217. Kathmandu Univ Med J (KUMJ). 2010. PMID: 22610735 Clinical Trial.
-
Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.Eye Sci. 2012 Dec;27(4):178-81. doi: 10.3969/j.issn.1000-4432.2012.04.005. Eye Sci. 2012. PMID: 23225838 Clinical Trial.
-
Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.J Neurol. 2001 Apr;248 Suppl 1:21-4. doi: 10.1007/pl00007813. J Neurol. 2001. PMID: 11357234 Review.
-
Use of botulinum toxin in neuro-ophthalmology.Curr Opin Ophthalmol. 2001 Dec;12(6):419-22. doi: 10.1097/00055735-200112000-00006. Curr Opin Ophthalmol. 2001. PMID: 11734681 Review.
Cited by
-
Profile of patients with essential blepharospasm and hemifacial spasm in the two largest ophthalmology reference centers in Brazil.Arq Bras Oftalmol. 2023 Oct 13;87(6):e20220160. doi: 10.5935/0004-2749.2022-0160. eCollection 2023. Arq Bras Oftalmol. 2023. PMID: 37851740 Free PMC article.
-
Efficacy of botulinum toxin in benign essential Blepharospasm: Desirable & undesirable effects.Pak J Med Sci. 2013 Nov;29(6):1389-93. doi: 10.12669/pjms.296.3853. Pak J Med Sci. 2013. PMID: 24550960 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical